BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38329151)

  • 1. Serum concentrations of complement C3 and C4 in dogs with idiopathic epilepsy.
    Kang S; Koo Y; Yun T; Chae Y; Lee D; Kim H; Yang MP; Kang BT
    J Vet Intern Med; 2024; 38(2):1074-1082. PubMed ID: 38329151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum induced opsonization of immunoglobulin G-coated polystyrene microspheres with complement components C3 and C4 as measured by flow cytometry.
    Spycher MO; Spycher-Burger M; Späth PJ; Burckhardt JJ
    J Immunol Methods; 1991 Dec; 145(1-2):83-92. PubMed ID: 1765669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement Levels in Nigeria Patients with Sickle Cell Anaemia in the Asymptomatic State.
    Okeke TI; P Musa BO; Babadoko AA; Jamoh BY
    Niger J Clin Pract; 2018 Sep; 21(9):1139-1143. PubMed ID: 30156198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
    Zinellu A; Mangoni AA
    Front Immunol; 2021; 12():696085. PubMed ID: 34163491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
    Zwirner J; Dobos G; Götze O
    J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement components (C3, C4) as inflammatory markers in asthma.
    Abdel Fattah M; El Baz M; Sherif A; Adel A
    Indian J Pediatr; 2010 Jul; 77(7):771-3. PubMed ID: 20589464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment.
    El-Fatah Fahmy Hanno A; Mohiedeen KM; Deghedy A; Sayed R
    Arab J Gastroenterol; 2014 Jun; 15(2):58-62. PubMed ID: 25097047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium and magnesium deficiency and C3 fraction of complement].
    Chevalier P; Cornu A; Delpeuch F; Joseph A
    C R Seances Acad Sci D; 1979 Jan; 288(2):267-70. PubMed ID: 111851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression and treatment response of idiopathic epilepsy in Australian Shepherd dogs.
    Weissl J; Hülsmeyer V; Brauer C; Tipold A; Koskinen LL; Kyöstilä K; Lohi H; Sauter-Louis C; Wolf M; Fischer A
    J Vet Intern Med; 2012; 26(1):116-25. PubMed ID: 22182230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The third (C3) and fourth (C4) components of complement in human liver. Immunocytochemical evidence for hepatocytes as the site of synthesis.
    Nagura H; Hasegawa H; Yoshimura S; Watanabe K
    Acta Pathol Jpn; 1985 Jan; 35(1):71-8. PubMed ID: 4003098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3 and C4 complement system components as biomarkers in the intermittent atopic asthma diagnosis.
    Mosca T; Menezes MC; Dionigi PC; Stirbulov R; Forte WC
    J Pediatr (Rio J); 2011; 87(6):512-6. PubMed ID: 22065014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of Detecting Serum Complement C3 and C4 in Patients with Multiple Myeloma].
    Li CJ; Xia HL; Wu YM; Ding G; Xu DD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):472-476. PubMed ID: 30998156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement systems C4, C3 and CH50 not subject to a circadian rhythm.
    Lung T; Matozan K; Risch M; Sakem B; Nydegger UE; Risch L
    Diagnosis (Berl); 2018 Jun; 5(2):77-82. PubMed ID: 29813028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of complement C3 and C4 components in Amerindians living in an area with high prevalence of tuberculosis.
    Araujo Z; González N; de Cubeddu L; Ziegler RC; de Waard JH; Giampietro F; Garzaro D; Pujol FH; de Serrano NC; de Saboin AG
    Mem Inst Oswaldo Cruz; 2006 Jun; 101(4):359-64. PubMed ID: 16951804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.
    Ritchie RF; Palomaki GE; Neveux LM; Navolotskaia O; Ledue TB; Craig WY
    J Clin Lab Anal; 2004; 18(1):1-8. PubMed ID: 14730550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid.
    Schenkein HA; Genco RJ
    J Periodontol; 1977 Dec; 48(12):778-84. PubMed ID: 338883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of the third component of complement in healthy dogs and dogs with protein-losing nephropathy.
    Acierno MJ; Labato MA; Stern LC; Mukherjee J; Jakowski RM; Ross LA
    Am J Vet Res; 2006 Jul; 67(7):1105-9. PubMed ID: 16817728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
    Ward M; Eastwood MA
    Digestion; 1975; 13(1-2):100-3. PubMed ID: 1201816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-bound complement activation products associate with lupus severity in SLE.
    Arriens C; Alexander RV; Narain S; Saxena A; Collins CE; Wallace DJ; Massarotti E; Conklin J; Kalunian KC; Putterman C; Ramsey-Goldman R; Buyon JP; Askanase A; Furie RA; James JA; Bello GA; Manzi S; Ahearn J; O'Malley T; Weinstein A; Dervieux T
    Lupus Sci Med; 2020 Apr; 7(1):. PubMed ID: 32371480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.